Literature DB >> 18191619

Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation.

Aude Marie-Cardine1, Florence Divay, Ingrid Dutot, Alexa Green, Anne Perdrix, Olivier Boyer, Nathalie Contentin, Hervé Tilly, François Tron, Jean-Pierre Vannier, Serge Jacquot.   

Abstract

Transitional B cells have been recently identified in human peripheral blood. However, their precise role in human B cell differentiation has not been established. Therefore, besides characterizing them further in the blood of healthy adults and children and cord blood, we used the immune reconstitution after hematopoietic stem cell transplantation (HSCT) model to define their role in human B cell development. Human transitional B cells are reliably identified as CD19(+) CD24(high) CD38(high) lymphocytes and represent approximately 4% of B cells in healthy adult peripheral blood. In contrast, they are abundant in cord blood (near 50% of B cells) and their percentage progressively decreases during infancy. Similarly, after HSCT, all B cells first appearing in peripheral blood are transitional B cells; afterwards, the transitional B cell percentage progressively decreases while the mature naïve B cell proportion rises. Our results now formally demonstrate that transitional B cells are necessary developmental intermediates for human mature B cell generation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18191619     DOI: 10.1016/j.clim.2007.11.013

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  50 in total

Review 1.  Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.

Authors:  Nicholas Chiorazzi; Manlio Ferrarini
Journal:  Blood       Date:  2010-12-09       Impact factor: 22.113

2.  IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation.

Authors:  Anushruti Sarvaria; Rafet Basar; Rohtesh S Mehta; Hila Shaim; Muharrem Muftuoglu; Ahmad Khoder; Takuye Sekine; Elif Gokdemir; Kayo Kondo; David Marin; May Daher; Amin M Alousi; Abdullah Alsuliman; Enli Liu; Betul Oran; Amanda Olson; Roy B Jones; Uday Popat; Chitra Hosing; Richard Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood       Date:  2016-07-20       Impact factor: 22.113

3.  Transitional B cell subsets in human bone marrow.

Authors:  S Agrawal; S A B C Smith; S G Tangye; W A Sewell
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

4.  Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells.

Authors:  Anouk Caraux; Bernard Klein; Bruno Paiva; Caroline Bret; Alexander Schmitz; Gwenny M Fuhler; Nico A Bos; Hans E Johnsen; Alberto Orfao; Martin Perez-Andres
Journal:  Haematologica       Date:  2010-01-15       Impact factor: 9.941

5.  Activation-induced cytidine deaminase expression and activity in the absence of germinal centers: insights into hyper-IgM syndrome.

Authors:  Masayuki Kuraoka; Dongmei Liao; Kaiyong Yang; Sallie D Allgood; Marc C Levesque; Garnett Kelsoe; Yoshihiro Ueda
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

Review 6.  Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications.

Authors:  Sophie Servais; Muriel Hannon; Régis Peffault de Latour; Gérard Socie; Yves Beguin
Journal:  Stem Cell Investig       Date:  2017-05-25

7.  Dynamics of B Cell Recovery In Kidney/Bone Marrow Transplant Recipients.

Authors:  Baoshan Gao; Yiming Gu; Chunshu Rong; Carolina Moore; Fabrice Porcheray; Waichi Wong; Frederic Preffer; Susan L Saidman; Yaowen Fu; Benedict Cosimi; David H Sachs; Tatsuo Kawai; Megan Sykes; Emmanuel Zorn
Journal:  Transplantation       Date:  2017-11       Impact factor: 4.939

8.  Nonpermissive bone marrow environment impairs early B-cell development in common variable immunodeficiency.

Authors:  Arianna Troilo; Claudia Wehr; Iga Janowska; Nils Venhoff; Jens Thiel; Justyna Rawluk; Natalie Frede; Julian Staniek; Raquel Lorenzetti; Marei-Theresa Schleyer; Georg W Herget; Lukas Konstantinidis; Miriam Erlacher; Michele Proietti; Nadezhda Camacho-Ordonez; Reinhard Edmund Voll; Bodo Grimbacher; Klaus Warnatz; Ulrich Salzer; Marta Rizzi
Journal:  Blood       Date:  2020-04-23       Impact factor: 22.113

9.  Immunologic reconstitution during PEG-ADA therapy in an unusual mosaic ADA deficient patient.

Authors:  Ping Liu; Ines Santisteban; Lauri M Burroughs; Hans D Ochs; Troy R Torgerson; Michael S Hershfield; David J Rawlings; Andrew M Scharenberg
Journal:  Clin Immunol       Date:  2008-10-25       Impact factor: 3.969

10.  Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis.

Authors:  Maria Rehnberg; Sylvie Amu; Andrej Tarkowski; Maria I Bokarewa; Mikael Brisslert
Journal:  Arthritis Res Ther       Date:  2009-08-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.